Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02035137
Title 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat (N2011-01)
Acronym N2011-01
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.